Integrated metabolomic and microbiome analysis identifies Cupriavidus metallidurans as a potential therapeutic target for beta-thalassemia. Guo X, Lin S, Zhang X, Li M, et al. Ann Hematol 2024;103:5169-5179.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Guo X, Lin S, Zhang X, Li M, et al. Integrated metabolomic and microbiome analysis identifies Cupriavidus metallidurans as a potential therapeutic target for beta-thalassemia. Ann Hematol 2024;103:5169-5179.
PMID: 39349606